share_log

Earnings Call Summary | Hamilton Beach Brands(HBB.US) Q4 2023 Earnings Conference

Earnings Call Summary | Hamilton Beach Brands(HBB.US) Q4 2023 Earnings Conference

業績電話會議摘要 | 漢密爾頓海灘品牌 (HBB.US) 2023 年第四季度業績發佈會
富途資訊 ·  03/08 03:11  · 電話會議

The following is a summary of the Hamilton Beach Brands Holding Company (HBB) Q4 2023 Earnings Call Transcript:

以下是漢密爾頓海灘品牌控股公司(HBB)2023年第四季度業績電話會議記錄摘要:

Financial Performance:

財務業績:

  • Hamilton Beach Brands reported a total revenue of $625.6 million for the year 2023, a 2.4% increase compared to 2022.

  • Gross profit margin expanded by 290 basis points to 23.0%.

  • Operating profit for 2023 was $35.1 million and net income was $25.2 million or $1.80 per diluted share.

  • The company achieved a record-high cash from operating activities at $88.6 million.

  • Q4 2023 net sales increased by 5.3% to $206.7 million.

  • 漢密爾頓海灘品牌報告稱,2023年的總收入爲6.256億美元,與2022年相比增長2.4%。

  • 毛利率增長了290個點子,達到23.0%。

  • 2023年的營業利潤爲3510萬美元,淨收入爲2520萬美元,攤薄後每股收益爲1.80美元。

  • 該公司的經營活動現金創歷史新高,達到8,860萬美元。

  • 2023年第四季度的淨銷售額增長了5.3%,達到2.067億美元。

Business Progress:

業務進展:

  • Scott Tidey was announced as the new President of the company.

  • Hamilton Beach introduced nearly 40 new product platforms in 2023 across high-demand categories.

  • The company's brand, Hamilton Beach Health, acquired Health Beacon, a medical technology company.

  • For FY 2024, the company estimates a modest growth in total revenue and a moderate increase in operating profit.

  • The company successfully reduced its net debt from $110 million in 2022 to $34.6 million as of December 31, 2023.

  • The company appears positive about potential M&A activities in the near future and is bullish on building its emerging 'Hamilton Beach Health' arm.

  • 斯科特·蒂迪被宣佈爲公司的新任總裁。

  • 漢密爾頓海灘在 2023 年推出了近 40 個新產品平台,涵蓋了需求旺盛的類別。

  • 該公司的品牌漢密爾頓海灘健康收購了醫療技術公司Health Beacon。

  • 該公司估計,2024財年的總收入將略有增長,營業利潤將適度增長。

  • 截至2023年12月31日,該公司成功將其淨負債從2022年的1.1億美元減少至3,460萬美元。

  • 該公司似乎對不久的將來潛在的併購活動持樂觀態度,並看好建立其新興的 “漢密爾頓海灘健康” 部門。

Tips: For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.

提示:欲了解更多詳情,請訪問投資者關係網站。本文僅供投資者參考,不構成任何投資建議。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論